References
- Weiner HL. Multiple sclerosis is an inflammatory T-cell-mediated autoimmune disease. Arch Neurol. 2004;61(10):1613–1615.
- Izadi S, Nikseresht A, Sharifian M, et al. Significant increase in the prevalence of multiple sclerosis in Iran in 2011. Iran J Med Sci. 2014;39(2):152.
- Sahraian MA, Khorramnia SA, Ebrahim MM, et al. Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time. Eur Neurol. 2010;64(6):331–336.
- Abdollahzadeh R, Jalilian N, Sahraian MA, et al. Polymorphisms of RPS6KB1 and CD86 associates with susceptibility to multiple sclerosis in Iranian population. Neurol Res. 2017;39(3):217–222.
- Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol. 2007;61(4):288–299.
- Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Ann Neurol. 2007;61(6):504–513.
- Huang J, Xie Z-F. Polymorphisms in the vitamin D receptor gene and multiple sclerosis risk: a meta-analysis of case–control studies. J Neurol Sci. 2012;313(1):79–85.
- Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. Lancet Neurol. 2010;9(6):599–612.
- Uitterlinden AG, Fang Y, Van Meurs JB, et al. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004;338(2):143–156.
- Bush WS, Moore JH. Genome-wide association studies. PLoS Comput Biol. 2012;8(12):e1002822.
- Smolders J, Peelen E, Thewissen M, et al. The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev. 2009;8(7):621–626.
- Miller S, Dykes D, Polesky H. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16:1215.
- Abdollahzadeh R, Fard MS, Rahmani F, et al. Predisposing role of vitamin D receptor (VDR) polymorphisms in the development of multiple sclerosis: a case–control study. J Neurol Sci. 2016;367:148–151.
- van der Mei IA, Ponsonby A-L, Dwyer T, et al. Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia. J Neurol. 2007;254(5):581.
- Kurtzke J. Epidemiology of multiple sclerosis. Does this really point toward an etiology? Lectio Doctoralis. Neurol Sci. 2000;21(6):383–403.
- Ogawa G, Mochizuki H, Kanzaki M, et al. Seasonal variation of multiple sclerosis exacerbations in Japan. Neurol Sci. 2004;24(6):417–419.
- Ozgocmen S, Bulut S, Ilhan N, et al. Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity. J Bone Miner Metab. 2005;23(4):309–313.
- Smolders J, Damoiseaux J, Menheere P, et al. Association study on two vitamin D receptor gene polymorphisms and vitamin D metabolites in multiple sclerosis. Ann N Y Acad Sci. 2009;1173(1):515–520.
- Bermúdez-Morales VH, Fierros G, Lopez RL, et al. Vitamin D receptor gene polymorphisms are associated with multiple sclerosis in Mexican adults. J Neuroimmunol. 2017;306:20–24.
- Gross C, Krishnan AV, Malloy PJ, et al. The vitamin D receptor gene start codon polymorphism: a functional analysis of FokI variants. J Bone Miner Metab. 1998;13(11):1691–1699.
- Arai H, Miyamoto K, Taketani Y, et al. A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Metab. 1997;12(6):915–921.
- Jurutka PW, Remus LS, Whitfield GK, et al. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factor IIB. Mol Endocrinol. 2000;14(3):401–420.
- van Etten E, et al. The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur J Immunol. 2007;37(2):395–405.
- Tizaoui K, Kaabachi W, Hamzaoui A, et al. Association between vitamin D receptor polymorphisms and multiple sclerosis: systematic review and meta-analysis of case–control studies. Cell Mol Immunol. 2015;12(2):243–252.
- Simon KC, Munger KL, Yang X, et al. Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis. Mult Scler J. 2010;16(2):133–138.
- Al-Temaimi RA, Al-Enezi A, Al-Serri A, et al. The association of vitamin D receptor polymorphisms with multiple sclerosis in a case–control study from Kuwait. PloS one. 2015;10(11):e0142265.
- Tajouri L, Ovcaric M, Curtain R, et al. Variation in the vitamin D receptor gene is associated with multiple sclerosis in an Australian population. J Neurogenet. 2005;19(1):25–38.
- Narooie-Nejad M, Moossavi M, Torkamanzehi A, et al. Vitamin D receptor gene polymorphism and the risk of multiple sclerosis in South Eastern of Iran. J Mol Neurosci. 2015;56(3):572–576.
- Agnello L, Scazzone C, Ragonese P, et al. Vitamin D receptor polymorphisms and 25-hydroxyvitamin D in a group of Sicilian multiple sclerosis patients. Neurol Sci. 2016;37(2):261–267.
- Smolders J, Damoiseaux J, Menheere P, et al. Fok-I vitamin D receptor gene polymorphism (rs10735810) and vitamin D metabolism in multiple sclerosis. J Neuroimmunol. 2009;207(1):117–121.
- Agliardi C, Guerini FR, Saresella M, et al. Vitamin D receptor (VDR) gene SNPs influence VDR expression and modulate protection from multiple sclerosis in HLA-DRB1* 15-positive individuals. Brain Behav Immun. 2011;25(7):1460–1467.
- García-Martín E, Agúndez JAG, Martínez C, et al. Vitamin D3 receptor (VDR) gene rs2228570 (Fok1) and rs731236 (Taq1) variants are not associated with the risk for multiple sclerosis: results of a new study and a meta-analysis. PloS one. 2013;8(6):e65487.
- Sioka C, Papakonstantinou S, Markoula S, et al. Vitamin D receptor gene polymorphisms in multiple sclerosis patients in northwest Greece. J Negat Results Biomed. 2011;10(1):3.
- Niino M, Fukazawa T, Yabe I, et al. Association of vitamin D receptor gene polymorphism in multiple sclerosis and the association with HLA class II alleles. J Neurol Sci. 2000;177(1):65–71.
- Kurtzke JF. Epidemiology of multiple sclerosis. Does this really point toward an etiology? LectioDoctoralis. Neurol Sci. 2000;21(6):383–403.